Cystourethroscopes

Welcome to Cystourethroscopes Site

Cystourethroscopes Resources

Home > Cystourethroscopes > [Correction] Correction for Steiner et al., Single-molecule studies of group II intron ribozymes

[Correction] Correction for Steiner et al., Single-molecule studies of group II intron ribozymes

Click Here to read the entire article...

Other Articles:

•	Altus Pharmaceuticals Announces Presentation Of Phase 3 Trizytek Efficacy Data At The North American Cystic Fibrosis Conference
	Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced that the Trizytek TM (liprotamase) Phase 3 efficacy study results will be presented at oral and poster sessions at the 2008 North American Cystic Fibrosis Conference (NACFC) in Orlando, FL on October 23 and 24. Trizytek is a non-porcine derived enzyme replacement therapy for patients with pancreatic insufficiency. The Phase 3 Trizytek efficacy results will be presented by Dr.
	Click Here to read the entire article...

•	Listen to The Lancet: 04 October
	The Roll Back Malaria partnership is 10-years old this month. An Editorial discusses the history and future of the partnership in light of their recently announced Global Malaria Business Plan to fund US $3 billion to tackle the disease; a podcast explores the implications.
	Click Here to read the entire article...

•	Cell Biologists Hail Senate Passage of Stem Cell Bill
	Expanding the number of human embryonic stem cells available for use by U.S. government-funded researchers was approved by the Senate with its passage of H.R. 810, 63 - 37. American Society for Cell Biology President Mary Beckerle praised the United
	Click Here to read the entire article...

•

	Click Here to read the entire article...

•	Medtech Startups, February 2008
	New medical technologies represented in companies added (February 2008) to the Medtech Startups Database and/or added to the February 2008 issue of MedMarkets: Company develops cryotherapy and cryosurgery ablation devices. It focuses on benign tumor and tissue ablation. Low-frequency ultrasound in wound healing. Company aims to deliver better solutions for patients and physicians in the areas of Biological Cartilage regeneration and endoscopic spine surgery. Medical devices Surgical instruments, including blunt dissection and tissue elevation instrument. Diabetes diagnostics; ocular-based blood glucose measurement. Biomaterials technologies for multiple medical device applications. Microwave ablation of liver, kidney and lung tumors. Implant technologies for peripheral nerve repair. Weight loss therapeutic developer device for opening obstructed airways (cricothyroidotomy) following traumatic injuries. Medical devices R&D company. Device to ease the pain of compression fractures of the spine by separating spinal bones and injecting fast-hardening cement. Now Published!: Worldwide Wound Management 2007-2016. see link For coverage in specific issues of MedMarkets, see link. For details on the Medtech Startups Database, see link. Tags: medtech, startup
	Click Here to read the entire article...

•	Male hormone patch increases libido in women (Reuters)
	Reuters - Postmenopausal women with low sexual desire levels reported improved sexual function after they were treated with a patch in which the male hormone testosterone was applied through the skin, a clinical study has found. However, more studies are needed to confirm the safety of this treatment.
	Click Here to read the entire article...